Pretargeted Molecular Imaging and Radioimmunotherapy
<p>Pretargeting is a multi-step process that first has an unlabeled bispecific antibody (bsMAb) localize within a tumor by virtue of its anti-tumor binding site(s) before administering a small, fast-clearing radiolabeled compound that then attaches to the other portion of the bsMAb. The compou...
Main Author: | David M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, William J, McBride, Robert M. Sharkey |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2012-01-01
|
Series: | Theranostics |
Online Access: | http://www.thno.org/v02p0523.htm |
Similar Items
-
Improved mehtods and reagents for pretargeted radioimmunotherapy of cancer
by: Zajic, Stefan C
Published: (2007) -
Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry
by: Otto C. Boerman
Published: (2014-11-01) -
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
by: Caroline eBodet-Milin, et al.
Published: (2015-11-01) -
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
by: Sofia H L Frost, et al.
Published: (2015-01-01) -
Development of an enzymatic pretargeting strategy for dual-modality imaging.
by: Knight, J, et al.
Published: (2015)